GUBRA
Founded in 2008, they are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. Their focus is the metabolic space (obesity, diabetes, NASH and diabetic complications), where we specialize in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS (next generation sequencing), bioinformatics and ex vivo assays. Gubra is an abbrevi... ation for GUt and BRAin, the original key focus areas of our research and expertise. They work with some of the most interesting and loyal partners and customers from across the world within big pharma, biotech and academia. Through a constant focus on high quality, scientific excellence, speed and solid teamwork, we have established ourselves as a highly professional and competent partner in the market.
GUBRA
Social Links:
Industry:
Biotechnology Health Care
Founded:
2008-01-01
Address:
Hørsholm, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.gubra.dk
Total Employee:
51+
Status:
Active
Contact:
+45 3152 Â2650
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
ALS Investment Fund
The ALS Investment Fund supports and finances biotech companies
CellAct Pharma
CellAct Pharma is a venture backed biotech company.
Prolongate
Prolongate is a protein drugs and biotech company.
Virometix
Virometix is a privately held biotechnology company developing
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.gubra.dk Semrush global rank: 4.72 M Semrush visits lastest month: 2.01 K
- Host name: 172.67.70.52
- IP address: 172.67.70.52
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Gubra"
Gubra - LinkedIn
Gubra | 17,212 followers on LinkedIn. Science of certainty | Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services ...See details»
Gubra - Crunchbase Company Profile & Funding
Gubra is a privately-held biotech companyFounded in 2008, they are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery …See details»
Gubra Company Profile - Office Locations, Competitors, Revenue …
Gubra has 5 employees at their 1 location and kr265.74 m in annual revenue in FY 2024. See insights on Gubra including office locations, competitors, revenue, financials, executives, …See details»
About Us | Gubra
Gubra is a highly specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The combination of our advanced, high …See details»
Gubra – Lex
Apr 25, 2025 Gubra er en bioteknologisk virksomhed, der yder kontraktforskning og tjenesteydelser inden for medicinsk forskning. Selskabet udvikler også medicin til forebyggelse …See details»
Gubra Welcomes New Board Members at 2025 AGM
Apr 3, 2025 Contacts at Gubra Media: Sofia Pitt Boserup, [email protected], +45 4188 9586 Investors: Kristian Borbos, [email protected], +45 3080 8035 About Gubra Gubra, founded in …See details»
Leadership - Gubra
About Us LeadershipThe leadership team is fully committed to driving Gubra’s success and growth. An unwavering focus on science, innovation, and execution lies at the heart of our efforts and we work relentlessly towards creating an …See details»
Record Quarter for Gubra, but Revised Outlook for…
3 days ago HORSHOLM, DENMARK / ACCESS Newswire / August 20, 2025 / Revenue and earnings for Gubra Group (CPH:GUBRA) have been record-high in the second quarter of 2025 …See details»
Gubra - Investor Relations
Jun 24, 2025 Corporate Overview Gubra, founded in 2008 in Denmark, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused …See details»
Corporate Governance - Gubra
Corporate Governance Gubra is committed to exercising good corporate governance at all times and the Board of Directors will regularly assess rules, policies, and practices according to the …See details»
Governance Documents - Gubra
Gubra Hørsholm Kongevej 11B 2970 Hørsholm Denmark [email protected] +45 3152 2650See details»
ESG | Gubra
At Gubra we strive to do business in a financially, environmentally, and socially responsible way – a focus we have had since Gubra was founded in 2008. To us ESG is not a destination, it is a …See details»
Gubra reports record high revenue and earnings in 2021 and …
May 23, 2022 Lead Communication Partner +45 41889586 [email protected] About Gubra Gubra is a privately held biotech company since 2008, headquartered in Denmark. The company is a …See details»
Preclinical CRO Services - All Models & Research Services | Gubra
Preclinical CRO Services Gubra offers expert preclinical research services enabling pharmaceutical and biotech companies to advance their drug development pipeline. Our …See details»
Gubra - Financial Reports
Check the types of releases you want to subscribe to.See details»
Gubra - Governance
Gubra Hørsholm Kongevej 11B 2970 Hørsholm Denmark [email protected] +45 3152 2650See details»
Gubra - News & Announcements - News Details - investors.gubra.dk
Feb 27, 2025 Today, Gubra released its Annual Report for 2024. Significant progress was made in 2024 across several R&D projects, not the least by advancement of the anti-obesity Amylin …See details»
Gubra - Contact - IR Contacts
Gubra Hørsholm Kongevej 11B 2970 Hørsholm Denmark [email protected] +45 3152 2650See details»
Gubra melder om rekordhøje tal i kvartalet | www.euroinvestor.dk ...
2 days ago Det danske biotekselskab Gubra er nu kommet med dugfriske tal for årets andet kvartal. Der er tale om rekordhøje tal - blandt andet når det drejer sig om omsætningen og den …See details»
Gubra præsenterer stort milliardoverskud efter kæmpe aftale
2 days ago Gubra præsenterer stort milliardoverskud efter kæmpe aftale Det danske selskab er braget frem i 2025 sammenlignet med sidste år. Det kommer blandt andet til udtryk på …See details»